A recent finding in human NSCLC revealed that over-expression of LAG-3 on TILs significant correlates with PD-1/PD-L1 expression, and the patients with both low expression of LAG-3 and PD-L1 indicate a favorable prognosis [44]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.